Details of the BTS
General Information of Binding Target of SBP (BTS) (ID: ST00002) | ||||||
---|---|---|---|---|---|---|
BTS Name |
Albumin
|
|||||
BTS Type |
Protein
|
|||||
Family |
ALB/AFP/VDB family
|
|||||
Gene Name |
ALB
|
|||||
Organism |
Homo sapiens (Human)
|
|||||
Function |
Binds water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs (Probable). Its main function is the regulation of the colloidal osmotic pressure of blood (Probable). Major zinc transporter in plasma, typically binds about 80% of all plasma zinc Major calcium and magnesium transporter in plasma, binds approximately 45% of circulating calcium and magnesium in plasma (By similarity). Potentially has more than two calcium-binding sites and might additionally bind calcium in a non-specific manner (By similarity). The shared binding site between zinc and calcium at residue Asp-273 suggests a crosstalk between zinc and calcium transport in the blood (By similarity). The rank order of affinity is zinc > calcium > magnesium (By similarity). Binds to the bacterial siderophore enterobactin and inhibits enterobactin-mediated iron uptake of E.coli from ferric transferrin, and may thereby limit the utilization of iron and growth of enteric bacteria such as E.coli Does not prevent iron uptake by the bacterial siderophore aerobactin
|
|||||
UniProt ID | ||||||
UniProt Entry | ||||||
PFam | ||||||
Gene ID | ||||||
Sequence |
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF
EDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP ERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF FAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV ARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK ECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR RHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE QLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV LNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL SEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV AASQAALGL |
|||||
Sequence Length |
609
|
|||||
Synthetic Binding Protein (SBP) Targeting This BTS |
---|
SBP Name | Highest Status | Mechanism | Affinity | Application | Details | Ref |
---|---|---|---|---|---|---|
ABD-derived affinity protein anti-ERBB2/HSA clone 1 | Research | Binder | Kd: 1 nM | Diagnostic reagent; Next generation protein therapeutics | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(A43V) | Research | Binder | Kd: 1.4 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(D6A) | Research | Binder | Kd: 1.7 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(R14A) | Research | Binder | Kd: 1.7 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(R35A) | Research | Binder | Kd: 2.3 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(S3A) | Research | Binder | Kd: 1.3 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone 1(V15A) | Research | Binder | Kd: 1 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-10 | Research | Binder | Kd: 1 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-12 | Research | Binder | Kd: 1 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-12(A8) | Research | Binder | Kd: 1.4 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-17 | Research | Binder | Kd: 1.3 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-18 | Research | Binder | Kd: 1 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-4 | Research | Binder | Kd: 0.6 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone FACS-5 | Research | Binder | Kd: 0.8 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone mat1 | Research | Binder | Kd: 20 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone mat3 | Research | Binder | Kd: 1.1 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB2/HSA clone mat6 | Research | Binder | Kd: 1.3 nM | Cancers [ICD-11: 2D4Z] | [1] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 1 | Research | Binder | Kd: 0.1 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 13 | Research | Binder | Kd: 0.8 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 18 | Research | Binder | Kd: 81 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 2 | Research | Binder | Kd: 0.3 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 20 | Research | Binder | Kd: 1.7 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 27 | Research | Binder | Kd: 1.8 nM | Research tool | [2] | |
ABD-derived affinity protein anti-ERBB3/HSA clone 3 | Research | Binder | Kd: 0.4 nM | Research tool | [2] | |
ABD-derived affinity protein anti-TNF-alpha/HSA clone 1 | Research | Binder | Kd: 1850 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA clone 2 | Research | Binder | Kd: 17 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA HT014 | Research | Binder | Kd: 39 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA HT015 | Research | Binder | Kd: 35 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA HT016 | Research | Binder | Kd: 68 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA T001 | Research | Binder | Kd: 192 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA T002 | Research | Binder | Kd: 649 nM | Research tool | [3] | |
ABD-derived affinity protein anti-TNF-alpha/HSA T004 | Research | Binder | Kd: 209 nM | Research tool | [3] | |
Human VH dAb anti-HSA VHB82(SS)-7 | Research | Binder | Kd: 5 nM | Research tool | [4] | |
I-body anti-CXCR4/HSA AD-114-Im7-FH-SA21 | Research | Binder | Kd: 518 nM | Cancers [ICD-11: 2D4Z]; Fibrosis [ICD-11: CA25.Z] | [5] | |
Macrocyclic peptide anti-HSA p1 | Research | Binder | Kd: 41 nM | Research tool | [6] | |
Macrocyclic peptide anti-HSA p2 | Research | Binder | Kd: 43 nM | Research tool | [6] | |
Nanobody anti-HSA clone b201 | Research | Binder | Kd: 430 nM | Research tool | [7] | |
vNAR anti-HSA huE06 v1.1 | Research | Neutralizer | N.A. | Research tool | [8] | |
vNAR anti-HSA huE06 v1.10 | Research | Neutralizer | N.A. | Research tool | [8] | |
vNAR anti-HSA huE06 v1.2 | Research | Neutralizer | N.A. | Research tool | [8] | |
vNAR anti-HSA huE06 v1.4 | Research | Neutralizer | N.A. | Research tool | [8] | |
References |
---|